Quantitative measurements of brain iron deposition in cirrhotic patients using susceptibility mapping

Acta Radiologica

Volumn 56, Issue 3, 2015, Pages 339-346

  Xia, Shuang ^a,b   Zheng, Gang ^a   Shen, Wen ^b   Liu, Saifeng ^c   Zhang, Long Jiang ^a   Haacke, E Mark ^d   Lu, Guang Ming ^a  

^a MEDICAL SCHOOL OF NANJING UNIVERSITY   (China)

^b TIANJIN FIRST CENTRAL HOSPITAL   (China)

^c MCMASTER UNIVERSITY   (Canada)

^d WAYNE STATE UNIVERSITY   (United States)

Author keywords

Cirrhosis; iron deposition; mapping; susceptibility weighted imaging

Indexed keywords

BIOMARKERS; BRAIN; DEPOSITION; DEPOSITS; IRON; IRON DEPOSITS; MAPPING;

CIRRHOSIS; CLINICAL BIOMARKERS; IRON DEPOSITION; NEUROPSYCHOLOGICAL TESTS; POSITIVE CORRELATIONS; QUANTITATIVE MEASUREMENT; SUSCEPTIBILITY MAPPING; SUSCEPTIBILITY WEIGHTED IMAGING;

BRAIN MAPPING;

ADULT; ARTICLE; AUTOPSY; BASAL GANGLION; BRAIN MAPPING; CAUDATE NUCLEUS; CLINICAL ARTICLE; CONTROLLED STUDY; DENTATE NUCLEUS; DIGIT SYMBOL TEST; FEMALE; GRAY MATTER; HUMAN; HUMAN TISSUE; INFORMED CONSENT; IRON STORAGE; LIVER CIRRHOSIS; MALE; MESENCEPHALON; NUCLEAR MAGNETIC RESONANCE SCANNER; NUMBER CONNECTION TEST TYPE A; PRIORITY JOURNAL; PSYCHOMETRY; RETROSPECTIVE STUDY; SUSCEPTIBILITY WEIGHTED IMAGING; WHITE MATTER; BLOOD; BRAIN; BRAIN DISEASES; BRAIN LEVEL; CADAVER; COMPLICATION; DISEASE PREDISPOSITION; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PROCEDURES; REFERENCE VALUE; STATISTICS AND NUMERICAL DATA;

BIOLOGICAL MARKER; IRON;

ADULT; BIOLOGICAL MARKERS; BRAIN; BRAIN CHEMISTRY; BRAIN DISEASES; BRAIN MAPPING; CADAVER; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; IRON; LIVER CIRRHOSIS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; REFERENCE VALUES; RETROSPECTIVE STUDIES;

EID: 84928424706     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1177/0284185114525374     Document Type: Article

References (32)

1. Chen HJ, Jiao Y, Zhu XQ, et al. Brain dysfunction primarily related to previous overt hepatic encephalopathy compared with minimal hepatic encephalopathy: Resting-state functional MR imaging demonstration. Radiology 2013; 266: 261-270.
2. McPhail MJ, Patel NR, Taylor-Robinson SD,. Brain imaging and hepatic encephalopathy. Clin Liver Dis 2012; 16: 57-72.
3. Rose C, Butterworth RF, Zayed J, et al. Manganese deposition in basal ganglia structures results from both portal-systemic shunting and liver dysfunction. Gastroenterology 1999; 117: 640-644.
4. Spahr L, Butterworth RF, Fontaine S, et al. Increased blood manganese in cirrhotic patients: relationship to pallidal magnetic resonance signal hyperintensity and neurological symptoms. Hepatology 1996; 24: 1116-1120.
5. Liem MK, Lesnik Oberstein SA, Versluis MJ, et al. 7 T MRI reveals diffuse iron deposition in putamen and caudate nucleus in CADASIL. J Neurol Neurosurg Psychiatry 2012; 83: 1180-1185.
6. Ropele S, de Graaf W, Khalil M, et al. MRI assessment of iron deposition in multiple sclerosis. J Magn Reson Imaging 2011; 34: 13-21.
7. Qin Y, Zhu W, Zhan C, et al. Investigation on positive correlation of increased brain iron deposition with cognitive impairment in Alzheimer disease by using quantitative MR R2' mapping. J Huazhong Univ Sci Technolog Med Sci 2011; 31: 578-585.
8. Xu X, Wang Q, Zhang M,. Age, gender, and hemispheric differences in iron deposition in the human brain: an in vivo MRI study. Neuroimage 2008; 40: 35-42.
9. Martinelli AL, Filho AB, Franco RF, et al. Liver iron deposits in hepatitis B patients: association with severity of liver disease but not with hemochromatosis gene mutations. J Gastroenterol Hepatol 2004; 19: 1036-1041.
10. Ghaziani T, Alavian SM, Zali MR, et al. Serum measures of iron status and HFE gene mutations in patients with hepatitis B virus infection. Hepatol Res 2007; 37: 172-168.
11. Klos KJ, Ahlskog JE, Kumar N, et al. Brain metal concentrations in chronic liver failure patients with pallidal T1 MRI hyperintensity. Neurology 2006; 67: 1984-1989.
12. Liu JY, Ding J, Lin D, et al. T2∗ MRI of minimal hepatic encephalopathy and cognitive correlates in vivo. J Magn Reson Imaging 2013; 37: 179-186.
13. Maffeo E, Montuschi A, Stura G, et al. Chronic acquired hepatocerebral degeneration, pallidal T1 MRI hyperintensity and manganese in a series of cirrhotic patients. Neurol Sci 2013 May 28. [Epub ahead of print].
14. Bilgic B, Pfefferbaum A, Rohlfing T, et al. MRI estimates of brain iron concentration in normal aging using quantitative susceptibility mapping. Neuroimage 2012; 59: 2625-2635.
15. Schweser F, Sommer K, Deistung A, et al. Quantitative susceptibility mapping for investigating subtle susceptibility variations in the human brain. Neuroimage 2012; 62: 2083-2100.
16. Langkammer C, Schweser F, Krebs N, et al. Quantitative susceptibility mapping (QSM) as a means to measure brain iron? A post mortem validation study. Neuroimage 2012; 62: 1593-1599.
17. Achiriloaie AF, Kido D, Wycliffe D, et al. White matter microsusceptibility changes in patients with hepatic encephalopathy. J Radiol Case Rep 2011; 5: 1-7.
18. Haacke EM, Tang J, Neelavalli J, et al. Susceptibility mapping as a means to visualize veins and quantify oxygen saturation. J Magn Reson Imaging 2010; 32: 663-676.
19. Zheng W, Nichol H, Liu S, et al. Measuring iron in the brain using quantitative susceptibility mapping and X-ray fluorescence imaging. Neuroimage 2013; 78: 68-74.
20. Hallgren B, Sourander P,. The effect of age on the non-haemin iron in the human brain. J Neurochem 1958; 3: 41-51.
21. Ferenci P, Lockwood A, Mullen K, et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
22. Haacke EM, Xu Y, Cheng YC, et al. Susceptibility weighted imaging (SWI). Magn Reson Med 2004; 52: 612-618.
23. Pandian DS, Ciulla C, Haacke EM, et al. Complex threshold method for identifying pixels that contain predominantly noise in magnetic resonance images. J Magn Reson Imaging 2008; 28: 727-735.
24. Storey JD,. A direct approach to false discovery rates. J Ro Stat Soc 2002; 64: 479-498.
25. Haacke EM, Cheng NY, House MJ, et al. Imaging iron stores in the brain using magnetic resonance imaging. Magn Reson Imaging 2005; 23: 1-25.
26. Abduljalil AM, Schmalbrock P, Novak V, et al. Enhanced gray and white matter contrast of phase susceptibility weighted images in ultra-high-field magnetic resonance imaging. J Magn Reson Imaging 2003; 18: 284-290.
27. Ogg RJ, Langston JW, Haacke EM, et al. The correlation between phase shifts in gradient-echo MR images and regional brain iron concentration. Magn Reson Imaging 1999; 17: 1141-1148.
28. Qi R, Zhang LJ, Xu Q, et al. Selective impairments of resting-state networks in minimal hepatic encephalopathy. PLoS One 2012; 7: e37400-e37400.
29. Zhang LJ, Qi R, Zhong J, et al. Disrupted functional connectivity of the anterior cingulate cortex in cirrhotic patients without overt hepatic encephalopathy: a resting state fMRI study. PLoS One 2013; 8: e53206-e53206.
30. Lockwood AH, Yap EW, Rhoades HM, et al. Altered cerebral blood flow and glucose metabolism in patients with liver disease and minimal encephalopathy. J Cereb Blood Flow Metab 1991; 112: 331-336.
31. Lockwood AH, Weissenborn K, Bokemeyer M, et al. Correlations between cerebral glucose metabolism and neuropsychological test performance in nonalcoholic cirrhotics. Metab Brain Dis 2002; 171: 29-40.
32. Zhang LJ, Zheng G, Zhang L, et al. Altered brain functional connectivity in patients with cirrhosis and minimal hepatic encephalopathy: a functional MR imaging study. Radiology 2012; 265: 528-536.